Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.

Journal of the National Cancer Institute - 1 Jan 2017

Shieh Yiwey, Eklund Martin, Madlensky Lisa, Sawyer Sarah D, Thompson Carlie K, Stover Fiscalini Allison, Ziv Elad, Van't Veer Laura J, Esserman Laura J, Tice Jeffrey A

Abstract excerpt

Ongoing controversy over the optimal approach to breast cancer screening has led to discordant professional society recommendations, particularly in women age 40 to 49 years. One potential solution is risk-based screening, where decisions around the starting age, stopping age, frequency, and modality of screening are based on individual risk to maximize the early detection of aggressive cancers and minimize the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Breast Density

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Magnetic Resonance Imaging

Share to Mammography

Share to Penetrance

Share to Practice Guidelines as Topic

Share to Precision Medicine

Source

Identifiers

PMID: 28130475
DOI: 10.1093/jnci/djw290

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.PMID 28130475Read ↗

Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial.Semantic proximity Read ↗

A clinical pilot study for personalized risk-based breast cancer screening utilizing the polygenic risk scoreSemantic proximity Read ↗

A clinical pilot study for personalized risk-based breast cancer screening utilizing a polygenic risk score.Semantic proximity Read ↗

Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.Semantic proximity Read ↗

The current status of risk-stratified breast screening.Semantic proximity Read ↗

Risk-based breast cancer screening strategies in women.Semantic proximity Read ↗

Toward more personalized breast cancer risk assessment: The polygenic risk score.Semantic proximity Read ↗

[Interest in the use of polygenic risk scores in breast cancer screening and preventive medicine].Semantic proximity Read ↗

Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.Semantic proximity Read ↗

Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection.Semantic proximity Read ↗

Genetics, Screening, and Risk-reducing Interventions for Breast Cancer.Semantic proximity Read ↗

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.